SEC Form 4 · accession 0000921895-26-001564
Starling Oncology, Inc. · STLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorey Chernett
10% Owner
Period of report
Jun 4, 2026
Accepted (ET)
Jun 5, 2026 · 9:38 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001799191
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2026 | P | 12,000 | $4.75 | A | 10,579,858 | D |
Table II — derivative securities
No Table II lines on this filing.